Patient demographics
| Characteristic | Patients (N=29) | % |
| Median age, years (range) | 48 (28–75) | – |
| Gender | ||
| Male | 15 | 52 |
| Female | 14 | 48 |
| Ethnicity | ||
| White | 21 | 72 |
| Black or African American | 2 | 8 |
| Hispanic | 3 | 10 |
| Asian | 3 | 10 |
| Location of primary tumor | ||
| Left-sided | 19 | 66 |
| Right-sided | 10 | 34 |
| Median # prior therapies | 2 (1–5) | – |
| Mutational status | ||
| KRAS/NRAS | 21 | 72 |
| BRAFV600E | 2 | 7 |
| RAS/RAF wild-type | 6 | 21 |
| Metastatic disease site | ||
| Lung | 15 | 52 |
| Liver | 18 | 62 |
| Lymph nodes | 8 | 28 |
| Peritoneum | 4 | 14 |
| Other | 2 | 7 |
| Consensus molecular subtype (CMS) | ||
| CMS4 | 9 | 31% |
| CMS3 | 2 | 7% |
| CMS2 | 12 | 41% |